BioXcel Therapeutics Inc
NASDAQ:BTAI 4:00:00 PM EDT
Market Cap (Intraday) | 111.82M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $3.93 |
50-Day MA | $3.50 |
200-Day MA | $12.87 |
BioXcel Therapeutics Inc Stock, NASDAQ:BTAI
555 Long Wharf Drive, 12th floor, New Haven, Connecticut 06511
United States of America
Phone: +1.475.238.6837
Number of Employees: 183
Description
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in developing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology. It also focuses on utilizing cutting-edge technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.